PREFER Partners
PREFER has 31 partners. The consortium is co-ordinated by Uppsala University, and managed together with Novartis that acts as project leader.
Academic institutions
- Uppsala University (Co-ordinator)
- Erasmus University Rotterdam
- European Institute of Oncology
- University Medical Centre Utrecht
- University of Birmingham
- University of Erlangen
- University of Leuven
- University of Newcastle upon Tyne
Patient organisations
- European Cancer Patients Coalition (ECPC)
- European Patient Forum (EPF)
- International Alliance of Patients’ Organizations (IAPO)
- Muscular Dystrophy UK (MDUK)
HTA-Bodies
Small and medium sized enterprises
Pharmaceutical Industry
- Novartis Pharma (Project Leader)
- AbbVie
- Actelion Pharmaceuticals
- Amgen
- Astellas Pharma Europe
- AstraZeneca
- Bayer
- CSL Behring
- Eli Lilly and Company
- Janssen
- Merck KGaA
- MSD
- Pfizer
- Roche
- Sanofi
- Takeda Development Centre Europe
